Alloantigen‐specific de novo‐induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD
暂无分享，去创建一个
A. Ganser | B. Malissen | A. Kissenpfennig | R. Förster | J. Huehn | I. Prinz | S. Schmitz | C. Koenecke | N. Czeloth | A. Bubke | Anja Bubke